BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18413814)

  • 21. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
    Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Yasui Y; Suzuki R; Kohno H; Miyamoto S; Beppu F; Hosokawa M; Miyashita K; Tanaka T
    Nutr Cancer; 2007; 59(1):82-91. PubMed ID: 17927506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats.
    Zhang Y; Li Q; Zhou D; Chen H
    Br J Nutr; 2013 Jan; 109(1):33-42. PubMed ID: 22716201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
    Magnuson BA; Carr I; Bird RP
    Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats.
    Parnaud G; Taché S; Peiffer G; Corpet DE
    Cancer Res; 1999 Oct; 59(20):5143-7. PubMed ID: 10537289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats.
    Paulsen JE; Steffensen IL; Olstørn HB; Alexander J
    Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
    Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
    Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat.
    Alabaster O; Tang Z; Frost A; Shivapurkar N
    Carcinogenesis; 1995 Jan; 16(1):127-32. PubMed ID: 7834797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T
    Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Cancer Res; 2003 Oct; 63(20):6595-601. PubMed ID: 14583451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM; Bird RP
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R; Yasui Y; Kohno H; Miyamoto S; Hosokawa M; Miyashita K; Tanaka T
    Oncol Rep; 2006 Nov; 16(5):989-96. PubMed ID: 17016582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fasting/refeeding enhances the crypt multiplicity in rat colon carcinogenesis induced by azoxymethane.
    Premoselli F; Sesca E; Chiara M; Binasco V; Tessitore L
    Boll Soc Ital Biol Sper; 1996; 72(9-10):239-45. PubMed ID: 9425720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
    Au A; Li B; Wang W; Roy H; Koehler K; Birt D
    Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.
    Izzo AA; Aviello G; Petrosino S; Orlando P; Marsicano G; Lutz B; Borrelli F; Capasso R; Nigam S; Capasso F; Di Marzo V;
    J Mol Med (Berl); 2008 Jan; 86(1):89-98. PubMed ID: 17823781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
    Miyamoto S; Yasui Y; Ohigashi H; Tanaka T; Murakami A
    Chem Biol Interact; 2010 Jan; 183(2):276-83. PubMed ID: 19914226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
    Momen MA; Monden Y; Houchi H; Umemoto A
    J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.